NaturalProductMech

Browse · Amino acids and peptides · cyclosporin A

cyclosporin A

CHEBI:4031 EXACT SEEDED antifungalcytotoxic

What these status tags mean

Curation status describes a workflow state. SEEDED means the record entered through the source-seeding workflow; it does not imply that no later curation occurred. PROPOSED marks an addition awaiting review; REVIEWED records curator sign-off on identity, structure, filing class and producer claims; DEPRECATED retains a superseded or out-of-scope record. These are workflow decisions, not independently verified human review. Agent-assisted contributions may appear in the record history.

Grounding describes the identifier mapping: EXACT uses an ontology identity asserted by the source; MINTED keeps a local identifier when no defensible ontology identity is available; REVIEW_NEEDED flags an exact structure whose ontology identity needs adjudication. The grounding note retains any unresolved alternatives. These tags do not establish the strength of producer or activity evidence.

A cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system, and therefore the risk of organ rejection. Also causes reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle.

Structure

Standard InChIKeyPMATZTZNYRCHOR-CGLBZJNRSA-N
SMILESCC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
Stereochemistryfully defined
Cross-referencespubchem:5284373

Filing pathway

Amino acids and peptides — computed by NPClassifier npclassifier.gnps2.org@2026-09-07, which is why it is pinned rather than recomputed. The gene cluster's asserted class is nrps, from MIBiG.

Producer organisms 1

A claim that this taxon makes the compound. The basis says what the evidence addressed — a knockout and a database assertion are not the same claim.

TaxonBasisClusterEvidence
Tolypocladium inflatum NRRL 8044
NCBITaxon:29910
SOURCE_ASSERTION mibig:BGC0000334 DOI:10.1371/journal.pgen.1003496

Occurrences 2

Somebody found the compound in this organism and cited it. That is not a claim that the organism makes it, and nothing here promotes one to the other.

TaxonSourceReference
Trichoderma polysporum
NCBITaxon:40695
LOTUS DOI:10.1002/HLCA.19760590412
Tolypocladium inflatum
NCBITaxon:29910
LOTUS DOI:10.1371/JOURNAL.PGEN.1003496

Biosynthetic gene clusters 1

AccessionHostLocus evidenceGenome
mibig:BGC0000334 Tolypocladium inflatum NRRL 8044
NCBITaxon:29910
CLUSTER_UNSTATED genbank:QEPI01000018.1

A locus claim and a taxon claim are different questions. Heterologous expression settles the first and leaves the second where the isolation report left it.

Mechanism & Biosynthesis Overview

PRODUCERS & OCCURRENCE 1 producer (0 causal) 2 cited occurrences BIOSYNTHETIC LOCUS 1 gene cluster 0 curated pathway steps NATURAL PRODUCT cyclosporin A CHEBI:4031 Amino acids and peptides TARGETS & BIOACTIVITY 0 molecular targets 25 bioactivities · 1 graph

Causal graph — bioactivity 6 nodes, 6 edges

Cyclosporin A binds human cyclophilin A, and the cyclosporin A-cyclophilin A complex binds the human calcineurin A/B phosphatase.

SubjectPredicateObjectNotesEvidence
cyclosporin A binds human cyclophilin A PDB 1MF8 contains cyclosporin A as chain D and maps the human cyclophilin A chain C to UniProtKB:P62937.
DOI:10.1073/PNAS.212504399
  • reference
    DOI:10.1073/PNAS.212504399
    evidence type
    PRIMARY_EXPERIMENT
    snippet
    Crystal Structure of Human Calcineurin Complexed with Cyclosporin a and Human Cyclophilin
    notes
    Jin and Harrison solved PDB 1MF8 with human calcineurin A, human calcineurin B, human cyclophilin A, and cyclosporin A.
cyclosporin A forms human cyclophilin A-cyclosporin A complex
DOI:10.1073/PNAS.212504399
  • reference
    DOI:10.1073/PNAS.212504399
    evidence type
    PRIMARY_EXPERIMENT
    snippet
    Crystal Structure of Human Calcineurin Complexed with Cyclosporin a and Human Cyclophilin
    notes
    Jin and Harrison solved PDB 1MF8 with human calcineurin A, human calcineurin B, human cyclophilin A, and cyclosporin A.
human cyclophilin A forms human cyclophilin A-cyclosporin A complex
DOI:10.1073/PNAS.212504399
  • reference
    DOI:10.1073/PNAS.212504399
    evidence type
    PRIMARY_EXPERIMENT
    snippet
    Crystal Structure of Human Calcineurin Complexed with Cyclosporin a and Human Cyclophilin
    notes
    Jin and Harrison solved PDB 1MF8 with human calcineurin A, human calcineurin B, human cyclophilin A, and cyclosporin A.
human calcineurin A alpha forms human calcineurin A/B complex
DOI:10.1073/PNAS.212504399
  • reference
    DOI:10.1073/PNAS.212504399
    evidence type
    PRIMARY_EXPERIMENT
    snippet
    Crystal Structure of Human Calcineurin Complexed with Cyclosporin a and Human Cyclophilin
    notes
    Jin and Harrison solved PDB 1MF8 with human calcineurin A, human calcineurin B, human cyclophilin A, and cyclosporin A.
human calcineurin B type 1 forms human calcineurin A/B complex
DOI:10.1073/PNAS.212504399
  • reference
    DOI:10.1073/PNAS.212504399
    evidence type
    PRIMARY_EXPERIMENT
    snippet
    Crystal Structure of Human Calcineurin Complexed with Cyclosporin a and Human Cyclophilin
    notes
    Jin and Harrison solved PDB 1MF8 with human calcineurin A, human calcineurin B, human cyclophilin A, and cyclosporin A.
human cyclophilin A-cyclosporin A complex binds human calcineurin A/B complex PDB 1MF8 maps human calcineurin A chain A to UniProtKB:Q08209 and human calcineurin B chain B to UniProtKB:P63098.
DOI:10.1073/PNAS.212504399
  • reference
    DOI:10.1073/PNAS.212504399
    evidence type
    PRIMARY_EXPERIMENT
    snippet
    Crystal Structure of Human Calcineurin Complexed with Cyclosporin a and Human Cyclophilin
    notes
    Jin and Harrison solved PDB 1MF8 with human calcineurin A, human calcineurin B, human cyclophilin A, and cyclosporin A.

Every edge carries its own citation; an uncited edge is refused by the corpus tests.

Bioactivities 25

Entries preserve source qualifiers, targets and evidence. Repeated assay names or values are not independent replications; inspect source detail for differences.

AssayResultTarget enzymeSource detail
A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Mycobacterium TuberculosisOTHER 22.12 uM; ACTIVENot recorded
pubchem.aid:435019
assay
A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Mycobacterium Tuberculosis
evidence
  • reference
    pubchem.aid:435019
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 435019, deposited by Southern Research Specialized Biocontainment Screening Center; assay type Confirmatory. Source endpoint: CC50.
call
ACTIVE
measurement type
OTHER
value
22.12
units
uM
activity class
CYTOTOXIC
A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of GlycerolIC50 99.57 uM; ACTIVENot recorded
pubchem.aid:449764
assay
A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of Glycerol
evidence
  • reference
    pubchem.aid:449764
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 449764, deposited by Southern Research Specialized Biocontainment Screening Center; assay type Confirmatory.
call
ACTIVE
measurement type
IC50
value
99.57
units
uM
A High-Content qHTS Against Drug Library for the Identification of Small Molecules that Inhibit DYT1 Early Onset Primary Dystonia-Associated Cell PathologyOTHER 1.5849 uM; NOT_DETERMINEDNot recorded
pubchem.aid:1645839
assay
A High-Content qHTS Against Drug Library for the Identification of Small Molecules that Inhibit DYT1 Early Onset Primary Dystonia-Associated Cell Pathology
evidence
  • reference
    pubchem.aid:1645839
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1645839, deposited by NCGC; assay type Confirmatory. Source outcome: Inconclusive. Source endpoint: Potency.
call
NOT_DETERMINED
measurement type
OTHER
value
1.5849
units
uM
A High-Content qHTS Against Drug Library for the Identification of Small Molecules that Inhibit DYT1 Early Onset Primary Dystonia-Associated Cell PathologyOTHER 1.5849 uM; NOT_DETERMINEDUniProtKB:O14656
pubchem.aid:1645839
assay
A High-Content qHTS Against Drug Library for the Identification of Small Molecules that Inhibit DYT1 Early Onset Primary Dystonia-Associated Cell Pathology
evidence
  • reference
    pubchem.aid:1645839
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1645839, deposited by NCGC; assay type Confirmatory. Source outcome: Inconclusive. Source endpoint: Potency.
call
NOT_DETERMINED
measurement type
OTHER
value
1.5849
units
uM
target enzyme
UniProtKB:O14656
A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.OTHER 0.631 uM; NOT_DETERMINEDNot recorded
pubchem.aid:624297
assay
A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.
evidence
  • reference
    pubchem.aid:624297
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 624297, deposited by NCGC; assay type Confirmatory. Source outcome: Inconclusive. Source endpoint: Potency. Target accession NP_056979 was left ungrounded because PubChem did not provide a UniProtKB accession.
call
NOT_DETERMINED
measurement type
OTHER
value
0.631
units
uM
Adrenergic beta2 receptor (ADRB2) small molecule agonists, cell-based qHTS assay: SummaryOTHER 0.565385 uM; NOT_DETERMINEDNot recorded
pubchem.aid:2061107
assay
Adrenergic beta2 receptor (ADRB2) small molecule agonists, cell-based qHTS assay: Summary
evidence
  • reference
    pubchem.aid:2061107
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 2061107, deposited by 824; assay type Summary. Source outcome: Inconclusive. Source endpoint: Potency.
call
NOT_DETERMINED
measurement type
OTHER
value
0.565385
units
uM
Adrenergic beta2 receptor (ADRB2) small molecule agonists, cell-based qHTS assay: SummaryOTHER 0.565385 uM; NOT_DETERMINEDNot recorded
pubchem.aid:2061107
assay
Adrenergic beta2 receptor (ADRB2) small molecule agonists, cell-based qHTS assay: Summary
evidence
  • reference
    pubchem.aid:2061107
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 2061107, deposited by 824; assay type Summary. Source outcome: Inconclusive. Source endpoint: Potency. Target accession NP_000015 was left ungrounded because PubChem did not provide a UniProtKB accession.
call
NOT_DETERMINED
measurement type
OTHER
value
0.565385
units
uM
Calcineurin Phosphatase (CaN) Assay from US Patent US10077289: "Cyclosporins modified on the MeBmt sidechain by heterocyclic rings"IC50 0.21 uM; ACTIVEUniProtKB:P48454
pubchem.aid:1795693
assay
Calcineurin Phosphatase (CaN) Assay from US Patent US10077289: "Cyclosporins modified on the MeBmt sidechain by heterocyclic rings"
evidence
  • reference
    pubchem.aid:1795693
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1795693, deposited by BindingDB; assay type Confirmatory.
call
ACTIVE
measurement type
IC50
value
0.21
units
uM
target enzyme
UniProtKB:P48454
Caspase-3/7 induction in CHO-K1 cells by small molecules, qHTS cell viability counter screenOTHER 10.0541 uM; ACTIVENot recorded
pubchem.aid:1346979
assay
Caspase-3/7 induction in CHO-K1 cells by small molecules, qHTS cell viability counter screen
evidence
  • reference
    pubchem.aid:1346979
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1346979, deposited by 824; assay type Confirmatory. Source endpoint: Potency.
call
ACTIVE
measurement type
OTHER
value
10.0541
units
uM
Caspase-3/7 induction in CHO-K1 cells by small molecules, qHTS cell viability counter screenOTHER 6.6824 uM; ACTIVENot recorded
pubchem.aid:1346979
assay
Caspase-3/7 induction in CHO-K1 cells by small molecules, qHTS cell viability counter screen
evidence
  • reference
    pubchem.aid:1346979
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1346979, deposited by 824; assay type Confirmatory. Source endpoint: Potency.
call
ACTIVE
measurement type
OTHER
value
6.6824
units
uM
Caspase-3/7 induction in HepG2 cells by small molecules, qHTS cell viability counter screenOTHER 15.9347 uM; ACTIVENot recorded
pubchem.aid:1346981
assay
Caspase-3/7 induction in HepG2 cells by small molecules, qHTS cell viability counter screen
evidence
  • reference
    pubchem.aid:1346981
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1346981, deposited by 824; assay type Confirmatory. Source endpoint: Potency.
call
ACTIVE
measurement type
OTHER
value
15.9347
units
uM
Caspase-3/7 induction in HepG2 cells by small molecules, qHTS cell viability counter screenOTHER 13.3332 uM; ACTIVENot recorded
pubchem.aid:1346981
assay
Caspase-3/7 induction in HepG2 cells by small molecules, qHTS cell viability counter screen
evidence
  • reference
    pubchem.aid:1346981
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1346981, deposited by 824; assay type Confirmatory. Source endpoint: Potency.
call
ACTIVE
measurement type
OTHER
value
13.3332
units
uM
Cell Viability qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteomeOTHER 0.1 uM; NOT_DETERMINEDNot recorded
PMID:33910017
assay
Cell Viability qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome
evidence
  • reference
    PMID:33910017
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1508629, deposited by NCGC; assay type Confirmatory. Source outcome: Inconclusive. Source endpoint: Potency.
call
NOT_DETERMINED
measurement type
OTHER
value
0.1
units
uM
Cellular viability qHTS for adrenocortical cancer (ACC) cell line NCI-H295ROTHER 23.1093 uM; NOT_DETERMINEDNot recorded
pubchem.aid:1963990
assay
Cellular viability qHTS for adrenocortical cancer (ACC) cell line NCI-H295R
evidence
  • reference
    pubchem.aid:1963990
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1963990, deposited by NCGC; assay type Confirmatory. Source outcome: Inconclusive. Source endpoint: Potency.
call
NOT_DETERMINED
measurement type
OTHER
value
23.1093
units
uM
Cellular viability qHTS for adrenocortical cancer (ACC) cell line SW-13OTHER 29.0929 uM; NOT_DETERMINEDNot recorded
pubchem.aid:1963989
assay
Cellular viability qHTS for adrenocortical cancer (ACC) cell line SW-13
evidence
  • reference
    pubchem.aid:1963989
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1963989, deposited by NCGC; assay type Confirmatory. Source outcome: Inconclusive. Source endpoint: Potency.
call
NOT_DETERMINED
measurement type
OTHER
value
29.0929
units
uM
Confirmatory qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assayOTHER 1.7783 uM; NOT_DETERMINEDNot recorded
PMID:33910017
assay
Confirmatory qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay
evidence
  • reference
    PMID:33910017
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1508628, deposited by NCGC; assay type Confirmatory. Source outcome: Inconclusive. Source endpoint: Potency.
call
NOT_DETERMINED
measurement type
OTHER
value
1.7783
units
uM
Counterscreen qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: GLuc-NoTag assayOTHER 8.9125 uM; NOT_DETERMINEDNot recorded
PMID:33910017
assay
Counterscreen qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: GLuc-NoTag assay
evidence
  • reference
    PMID:33910017
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1508627, deposited by NCGC; assay type Confirmatory. Source outcome: Inconclusive. Source endpoint: Potency.
call
NOT_DETERMINED
measurement type
OTHER
value
8.9125
units
uM
Cyclophilin Peptidyl-Prolyl Isomerase Functional Assay from US Patent US12522634: "Cyclophilin inhibitors and uses thereof"KI 0.0091 uM; ACTIVEUniProtKB:P23284
pubchem.aid:2282760
assay
Cyclophilin Peptidyl-Prolyl Isomerase Functional Assay from US Patent US12522634: "Cyclophilin inhibitors and uses thereof"
evidence
  • reference
    pubchem.aid:2282760
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 2282760, deposited by BindingDB; assay type Confirmatory.
call
ACTIVE
measurement type
KI
value
0.0091
units
uM
target enzyme
UniProtKB:P23284
Cyclophilin Peptidyl-Prolyl Isomerase Functional Assay from US Patent US12522634: "Cyclophilin inhibitors and uses thereof"KI 0.0078 uM; ACTIVEUniProtKB:P62937
pubchem.aid:2282760
assay
Cyclophilin Peptidyl-Prolyl Isomerase Functional Assay from US Patent US12522634: "Cyclophilin inhibitors and uses thereof"
evidence
  • reference
    pubchem.aid:2282760
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 2282760, deposited by BindingDB; assay type Confirmatory.
call
ACTIVE
measurement type
KI
value
0.0078
units
uM
target enzyme
UniProtKB:P62937
Cytochrome P450 Family 1 Subfamily A Member 2 (CYP1A2) small molecule antagonists: luciferase reporter qHTS assayOTHER 13.1044 uM; ACTIVENot recorded
pubchem.aid:1671199
assay
Cytochrome P450 Family 1 Subfamily A Member 2 (CYP1A2) small molecule antagonists: luciferase reporter qHTS assay
evidence
  • reference
    pubchem.aid:1671199
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1671199, deposited by 824; assay type Confirmatory. Source endpoint: Potency.
call
ACTIVE
measurement type
OTHER
value
13.1044
units
uM
Cytochrome P450 Family 1 Subfamily A Member 2 (CYP1A2) small molecule antagonists: luciferase reporter qHTS assayOTHER 13.1044 uM; ACTIVENot recorded
pubchem.aid:1671199
assay
Cytochrome P450 Family 1 Subfamily A Member 2 (CYP1A2) small molecule antagonists: luciferase reporter qHTS assay
evidence
  • reference
    pubchem.aid:1671199
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1671199, deposited by 824; assay type Confirmatory. Source endpoint: Potency. Target accession EAW99313 was left ungrounded because PubChem did not provide a UniProtKB accession.
call
ACTIVE
measurement type
OTHER
value
13.1044
units
uM
Cytochrome P450 Family 2 Subfamily C Member 19 (CYP2C19) small molecule antagonists: luciferase reporter qHTS assayOTHER 5.8535 uM; ACTIVENot recorded
pubchem.aid:1671197
assay
Cytochrome P450 Family 2 Subfamily C Member 19 (CYP2C19) small molecule antagonists: luciferase reporter qHTS assay
evidence
  • reference
    pubchem.aid:1671197
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1671197, deposited by 824; assay type Confirmatory. Source endpoint: Potency.
call
ACTIVE
measurement type
OTHER
value
5.8535
units
uM
Cytochrome P450 Family 2 Subfamily C Member 19 (CYP2C19) small molecule antagonists: luciferase reporter qHTS assayOTHER 5.8535 uM; ACTIVENot recorded
pubchem.aid:1671197
assay
Cytochrome P450 Family 2 Subfamily C Member 19 (CYP2C19) small molecule antagonists: luciferase reporter qHTS assay
evidence
  • reference
    pubchem.aid:1671197
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1671197, deposited by 824; assay type Confirmatory. Source endpoint: Potency. Target accession AAV41877 was left ungrounded because PubChem did not provide a UniProtKB accession.
call
ACTIVE
measurement type
OTHER
value
5.8535
units
uM
Cytochrome P450 Family 2 Subfamily C Member 19 (CYP2C19) small molecule antagonists: luciferase reporter qHTS assayOTHER 8.709 uM; ACTIVENot recorded
pubchem.aid:1671197
assay
Cytochrome P450 Family 2 Subfamily C Member 19 (CYP2C19) small molecule antagonists: luciferase reporter qHTS assay
evidence
  • reference
    pubchem.aid:1671197
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1671197, deposited by 824; assay type Confirmatory. Source endpoint: Potency.
call
ACTIVE
measurement type
OTHER
value
8.709
units
uM
Cytochrome P450 Family 2 Subfamily C Member 19 (CYP2C19) small molecule antagonists: luciferase reporter qHTS assayOTHER 8.709 uM; ACTIVENot recorded
pubchem.aid:1671197
assay
Cytochrome P450 Family 2 Subfamily C Member 19 (CYP2C19) small molecule antagonists: luciferase reporter qHTS assay
evidence
  • reference
    pubchem.aid:1671197
    evidence type
    DATABASE_ASSERTION
    notes
    PubChem BioAssay AID 1671197, deposited by 824; assay type Confirmatory. Source endpoint: Potency. Target accession AAV41877 was left ungrounded because PubChem did not provide a UniProtKB accession.
call
ACTIVE
measurement type
OTHER
value
8.709
units
uM
notes
318 further PubChem assay results are in data/raw/pubchem_bioassay.tsv but not written here.

Elsewhere in the fleet

Explore across X-Mech

Provenance

Source conceptSourceVersion
BGC0000334MIBIG4
CHEBI:4031CHEBI3-star

This page is generated from data/natural_products/amino_acids_and_peptides/cyclosporin-a.yaml, which is generated from the committed inventories. Neither is edited by hand.